<DOC>
	<DOCNO>NCT01377792</DOCNO>
	<brief_summary>A phase IV clinical trial , multicentric ( 3 Hospitals Madrid ) control , prospective , open randomize long-term treatment hypertonic saline cystic fibrosis patient . The purpose study verify long term inhalation ( 48 week ) major volume ( 10 ml ) increase free time without pulmonary exacerbation , increase superior obtain inhalation standard volume ( 5 ml ) advocate .</brief_summary>
	<brief_title>Study Long-term Treatment With Hypertonic Saline Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Clinical diagnosis Cystic fibrosis Over 6 year old FEV1 30 % Must able perform spirometry Must able perform induce sputum Must tolerate maximum dose 10 ml hypertonic saline No oral neither intravenous treatment within previous 2 week begin study No treatment hypertonic saline 2 week No clinical diagnosis Cystic Fibrosis No tolerance 10 ml hypertonic saline Positive pregnancy test No tolerance Beta2agonist Treatment corticosteroid FEV1 &lt; 30 % Liver and/or lung transplantation Oxygen treatment Hospital admission within 4 previous week Oral intravenous antibiotic treatment within 2 previous week Smokers Pulmonary colonisation Burkholderia cepacia complex</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>hypertonic saline</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>pulmonary inflammation</keyword>
	<keyword>pulmonary exacerbation</keyword>
</DOC>